Keeping Track: Novel Oncologics Submitted By Taiho, ImmunoGen, Y-mAbs; US FDA Declines Akebia’s Vadadustat

 
• By Bridget Silverman
Keeping Track Feature image

More from Archive

More from Pink Sheet